| |
NeuroResearch Clinics, Inc. |
| |
AMA Category 1
|
| |
Continuing Medical Education |
|
|
|
|
|
|
 |
The side effect profile of 5-HTP aka 5HTP or 5
HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa are similar to placebo
(sugar pill) when it appears that a major side
effect has occurred with starting or changing
the 5-HTP aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine and
L-dopa aka dopa dosing it
is usually a coincidental event. This link leads
to the side effect profile for patients taking
5-HTP aka 5HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa
aka dopa with no
prescription medications. |
|
About 1 patient in 200 will experience GI upset
(upset stomach) on starting 5-HTP aka 5HTP or 5
HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa. This happens in the
patient who are most depleted of
serotonin and dopamine neurotransmitter molecules. While this side effect is
unpleasant when this happens this is the patient
who needs the 5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa
the most to replenish serotonin and dopamine neurotransmitter molecules. This
link talks about strategies for managing GI
upset on start up. |
 |
 |
Serotonin and norepinephrine neurotransmitter
molecules control the
appetite center of the brain. When taking 5-HTP
aka 5HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa
aka dopa some patients may
experience a change in the way their body reacts
to certain foods (carbohydrates). This link
discusses management of carbohydrate
intolerance. |
|
20% of patients who take cysteine in the morning
experience nausea for about 15 to 20 minutes.
This link discusses how to manage this
problem. |
 |
 |
Not only do the 5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and
L-dopa aka dopa allow drugs that work with serotonin,
dopamine, norepinephrine, and epinephrine
neurotransmitter molecules to
work optimally. They may also cause the drugs
work with the neurotransmitter molecules
serotonin, dopamine, norepinephrine, and
epinephrine to
display a drug side effect. This link discusses
management of drug side
effects. |
|
The 5-HTP aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine, and
L-dopa aka dopa dosing
protocols developed by NeuroResearch are based
on analysis of huge data bases with many
thousands of patients under serotonin and
dopamine neurotransmitter treatment from hundreds of clinics.
In doing so the goal was to maximize
effectiveness and minimize side effects of 5-HTP
aka 5HTP or 5 HTP, tyrosine aka L-tyrosine, and
L-dopa aka dopa. This
link discusses the problems seen when care givers
deviate from the protocols. |
 |
|
|
A paradoxical reaction is when the symptoms of
the serotonin and dopamine neurotransmitter disease
such as depression, ADHD, etc. being treated gets worse. These
links discuss the proper management of
paradoxical reactions so the they do not
interfere with the depression, ADHD, etc. patient getting
better. |
|
Heart burn when taking the pills is not caused
by the pill but from the way the pills are taken
this link discusses management of
this problem. |
 |
 |
Dizziness is easily managed by increasing the
5-HTP aka 5HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa
aka dopa dosing. This
link discusses how this works and how to manage
patients with complaints of
dizziness. |
|
When patients starting 5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine,
and L-dopa aka dopa complain of feeling overly tired it
can be a problem. This link discusses management
of this problem. |
 |
|
| |
| PATIENT SIDE
EFFECT |
| INFORMATION SHEETS |
| |
|
|
| |
|
|
|
| |
|
|
| |
|
SIDE EFFECTS |
|
In
taking 5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and
L-dopa aka dopa there is no side
effect that should require stopping on a
permanent basis if managed properly. At
the left links to management strategies
and patient hand outs relating to side
effects. |
|
|
|
|
|
| |
|
|
| 5-HTP aka
5HTP or 5 HTP
1 |
 |
|
|
|
|
|
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa |
|
|
|
SIDE
EFFECT PROFILE |
| |
|
No patient should
have to stop serotonin and dopamine neurotransmitter therapy due to side effects, if
the 5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa is used properly in the medical
practice. |
| |
|
The follow represents over 50
patient-years of data from patients
taking the serotonin and dopamine
neurotransmitter precursors 5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and
L-dopa aka dopa with no drugs. |
|
|
|
|
|
THE GROUP ANALYZED: |
|
Regarding the following side effect
profile: |
| Ø
It is the Incidence of side effects
reported at serotonin and dopamine neurotransmitter patient visits. |
| Ø A
database grouping of 494 serotonin and dopamine
neurotransmitter patients. |
| Ø
It
represents 1,604 serotonin and dopamine neurotransmitter patient visits. |
| Ø
Patients were under serotonin and
dopamine neurotransmitter precursors treatment with
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa only. |
| Ø Patients
taking serotonin and dopamine neurotransmitter prescription drugs that might have effect on
serotonin and dopamine neurotransmitter molecules were excluded. |
| Ø Patients
were from practices that had mastered use of serotonin
and dopamine neurotransmitter precursors of
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa
therapy. |
| Ø
The data represents 50 patient-years of
serotonin and dopamine neurotransmitter treatment. |
| |
|
INCIDENCE OF SIDE EFFECTS REPORTED AT > 0.2% OF VISITS. |
| Ø
Dry mouth ---- 34 (2.1%) |
| Ø
Insomnia ------ 14 (0.9%) |
| Ø
Headache ----- 12 (0.7%) |
| Ø
Nausea -------- 10 (0.6%) |
| Ø
Dizziness ------- 6 (0.4%) |
| Ø
Constipation --- 6 (0.4%) |
|
|
|
INCIDENCE OF SIDE EFFECTS REPORTED AT <
0.2% OF VISITS. |
|
Moodiness, cold extremities, cravings,
diarrhea, drowsy, irritability, fingers tingle, sweats,
jittery, fatigue, flatulence, palpitations, flush face,
hypoglycemia, light headed, sore tongue (glossitis),
depression, thirst, abdominal pain, abdominal burning,
spots before eyes, non-specific dermatitis. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5-HTP aka 5HTP or 5 HTP 2 |
 |
| |
|
|
|
|
|
|
|
GI upset (98% of start
up problems) and other problems that
occur on the starting of serotonin and
dopamine neurotransmitter precursors
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa can be
managed properly and easily. With GI
upset the typical scenario is that the
patient experiences GI upset with the
first dose of serotonin and dopamine
neurotransmitter precursors
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa. The GI upset
then builds until day 3 at which point
the patient quits the serotonin and
dopamine neurotransmitter precursors
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa. |
|
|
From our work we know
that start up GI upset occurs in the
patients that are most depleted of
serotonin and dopamine neurotransmitter
molecules. These are the patients who
need
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa therapy the most.
Patients who have recently (in the last
18 to 24 months) been on certain
serotonin and dopamine drugs
that deplete serotonin and dopamine neurotransmitter molecules can
experience this problem at an increased
rate. A nutrient poor diet can also
contribute to this problem as well as
other mechanisms of action. |
|
|
|
|
So how is this managed
properly? FIRST you need to
tell all patients starting serotonin and
dopamine neurotransmitter precursors
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa
therapy, “If you have problems with
upset stomach as you start the pills,
quit the pills until you can get back
into the office for instructions on how
to manage the problem." Simply doing this
will keep new patients from dropping out
of treatment if problems with GI upset
are encountered. |
|
When a patient returns complaining of
GI upset or other start up problems the proper
management is to simply cut back the dosing to one pill
at bed time. Bedtime is when the patient is ready to go
to sleep not ready get in bed and read a book. If
patients with start up problems can take the one pill
and fall asleep within 15 to 20 minutes the problems do
not crop up. Patients who have experienced GI upset on
start up have reported that eating one or two “soda
crackers” before taking the pills at bed time also helps
the problem, but we have no studies on this. After the
patient has had no symptoms for 3 to 4 days, add an
additional pill at bedtime and continue to increase
dosing in a similar manner until the patient is on 4
pills at bed time then start adding one pill in the AM
in a similar manner until the patient is at the
starting dose of 8 pills a day. Once the
patient is on 8 pills a day of the serotonin and
dopamine neurotransmitter precursors
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa dosing can be
titrated upward as per usual with the
NeuroResearch serotonin and dopamine
neurotransmitter precursors
treatment protocols until
therapeutic serotonin and dopamine neurotransmitter levels are established as
verified by urinary serotonin and dopamine
neurotransmitter lab testing and clinical observations. It
generally takes 3 to 4 weeks to get patients with
serotonin and dopamine neurotransmitter levels up to
the
starting dose of
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa (8 pills a day). |
|
|
From the database where the incidence
of GI upset on start up is 0.5%, although we have seen
practices where the incidence is much higher, such as
the practice of an addictionologist or practices that
were using large amounts of drugs that had a propensity
for depleting serotonin and dopamine neurotransmitter molecules. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5-HTP aka 5HTP or 5 HTP 3 |
 |
|
|
|
In 1999 as we pushed
the dosing of
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa higher and got
rid of prescription drugs that work with
serotonin and dopamine neurotransmitter
molecules from the
picture in treatment we began to get
reports of patients who were
experiencing GI upset several weeks or
months into treatment. Initially we
thought this was from serotonin and
dopamine neurotransmitter
depletion, but it did not make sense.
How could patients under treatment for
several weeks or months now be
experiencing serotonin and dopamine
neurotransmitter depletion problems? It took
us seven months of intensive serotonin
and dopamine neurotransmitter patient
care to find the answer. These patients
all were fully adjusted out on their
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa to obtain the desired
serotonin and dopamine neurotransmitter clinical response and the answer was
that they were experiencing problems
with “carbohydrate intolerance”. These
were primarily medical weight loss
patients who need higher levels of
serotonin and dopamine neurotransmitter molecules and
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa to
obtain the desired response. In weight
loss as patients are placed in appetite
suppression with prescription serotonin
and norepinephrine drugs and/or
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa, in many patients the
physical response is to food changes. In
this case it was their response to
carbohydrates. We found that it was not
all carbohydrates but highly selective
and usually involved just one
carbohydrate. Typically the GI upset
occurred in the morning about 2 to 3
hours after breakfast, although the
problem could be seen anytime during the
day. Most common foods were breads,
noodles, and cereals, although rare
cases were seen such as the woman who
ate fried chicken almost every day and
the problem was tracked down to the
breading on the chicken. The treatment
is to simply remove or change the food
involved. For example, I had a 54 year
old male present for a clinic visit at
10 AM who was complaining of GI upset at
the clinic visit. I asked him, “What did
you ear for breakfast?” He said, “Two
eggs and two pieces of white bread”. I
immediately said, “It is your bread.” He
changed from white bread to whole wheat
bread and never had another problem
until a month later when he ate a piece
of white bread. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5-HTP aka 5HTP or 5 HTP 4 |
 |
|
|
|
|
|
GI UPSET FROM CYSTEINE |
|
|
|
Tyrosine aka L-tyrosine and L-dopa aka
dopa deplete the sulfur amino acids if
proper levels of cysteine are not
administered with their use. |
|
All patients
taking a combination of
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa
precursors of the serotonin, dopamine, norepinephrine
and epinephrine systems need to take
proper amounts of cysteine two pills
three times a day to prevent
depletion of the sulfur amino acid
system. It has been observed in clinics
that 20% of patients taking cysteine in
the early morning experience GI upset.
The mechanism of action of this problem
is unknown but the treatment is to
instruct patients at the start of
treatment to take the cysteine at noon,
4 or 5 PM, and bed time. From time to
time you will run into a patient who did
not understand the instructions and is
taking cysteine in the AM with no
problems, this is fine. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5-HTP aka 5HTP or 5 HTP 5 |
 |
|
|
|
Drugs that work with
serotonin and dopamine neurotransmitter molecules do not work if there
are not enough serotonin and dopamine neurotransmitter
molecules in the system to work
with. Drugs that work by redistributing
serotonin and dopamine neurotransmitter
molecules from one place to
another in the brain such as reuptake
inhibitor depression and ADHD drugs deplete
serotonin and dopamine neurotransmitter molecules in the long run in
most patients. When this happens
reuptake inhibitor depression and ADHD drugs
quit working and the symptoms depression
and ADHD return. |
|
The recommendation for
depression, ADHD, etc. treatment is to simply leave the patient
on any reuptake inhibitor prescription
depression, ADHD, etc. drugs they may be on
at initiation of
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa
serotonin and dopamine neurotransmitter therapy
until the patient is stabilized on the
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa. Another consideration
exists here. As the patient with
diminished effects of prescription
reuptake inhibitor depression, ADHD,
etc. drugs
is started on
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa therapy, not
only the effects of the reuptake
inhibitor depression, ADHD, etc. drugs once again
become fully evident, the side effects
of the reuptake inhibitor depression,
ADHD, etc. drugs also become evident.
This occurs in approximately 3% to 5% of
patients and is more prominent in
patients taking a dosing of reuptake
inhibitor depression, ADHD, etc. drugs that
is higher than the starting dose. If
patients early on in reuptake inhibitor
depression, ADHD, etc. drug treatment
experience symptoms not list above under
side effect profile and are on
other prescription drugs, the work with
serotonin or dopamine neurotransmitter molecules, review the side
effects of the reuptake inhibitor
depression, ADHD, etc. drugs involved in the
PDR. Odds are that the patient is
experiencing a drug side effect and the
treatment is to lower the daily dosing
of the drug instead of cut back on the
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa dosing. |
|
|
|
|
PRESCRIPTION DRUG SIDE
EFFECTS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5-HTP aka 5HTP or 5 HTP 6 |
 |
|
|
|
|
|
REFORMULATION OF 5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa |
|
|
|
The
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa formulas
with serotonin and dopamine
neurotransmitter protocols of NeuroResearch
were formulated for optimal group
results AND to minimize side effects.
Use of
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa
outside of the
NeuroResearch guidelines is associated
as an increase in side effects above
those listed at the top of this web page. Also of confusion is the
fact that there are
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa formulas
out there for treatment of
serotonin and dopamine neurotransmitter disease
such as depression, ADHD, etc.
that were not
scrutinized properly in
order to minimize side effects in
clinical applications. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5-HTP aka 5HTP or 5 HTP 7 |
 |
|
|
|
PARADOXICAL
REACTIONS |
|
|
|
|
|
I
received a call from a physician who reported that a
weight patient started the level 1
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa dosing and
experienced a profound exacerbation of depression. In
responding, the physician had changed the
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa
dosing by significantly lowering the dopamine precursor,
while increasing the serotonin precursor with no relief. |
|
The
real problem was the patient was experiencing a
“paradoxical reaction” - an exacerbation of depression.
When starting
5-HTP aka 5HTP or 5 HTP, tyrosine aka L-tyrosine, and
L-dopa aka dopa therapy with weight patients or
other serotonin and dopamine neurotransmitter patients, it is not uncommon for a paradoxical
reaction to occur in approximately 2 to 4% of patients.
The proper approach to manage paradoxical reactions is
to increase the
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa dosing of both the
serotonin and dopamine precursors to the next level,
then paradoxical symptoms will resolve in 1 to 2 days.
Unless guided by a urinary serotonin and dopamine
neurotransmitter laboratory test, it is best to use
the recommended level changes and not lower the
precursor dosing of one system and raise the dosing of
the other. |
|
When
faced with a paradoxical reaction, if you decrease the
5-HTP aka 5HTP
or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa dosing, you will not resolve the paradoxical
reaction, you will simply leave your patient suffering
needlessly and never get to where you need to go.
Proper management of a paradoxical
reaction is to increase the
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa dosing of both
the dopamine and serotonin systems. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5-HTP aka 5HTP or 5 HTP 8 |
|
|
|
|
|
|
|
MORE ON PARADOXICAL
SIDE EFFECTS |
|
|
|
|
|
|
|
When
serotonin
and dopamine neurotransmitter precursors 5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa dosing
is started or increased, some patients
experience an increase in their
serotonin and dopamine neurotransmitter disease
symptoms
such as depression, ADHD, etc. This
is known as a “Paradoxical Reaction.”
Some common examples of paradoxical
reactions are: |
|
Ø
Depression becomes worse. |
|
Ø
Sleep becomes worse |
|
Ø
The weight loss patient’s
appetite increases. |
|
Ø
Anxiety
becomes worse. |
|
Ø
Migraine headaches become
worse. |
|
Any serotonin or
dopamine related neurotransmitter
dysfunction disease
such as depression, ADHD, etc.
can display a
paradoxical reaction during treatment. |
|
|
|
If you
encounter a paradoxical reaction in your patients, treat
by increasing the
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa dosing to the next level of
treatment. Physicians are trained to decrease or stop
prescription serotonin and dopamine reuptake inhibitor drugs if a problem is encountered. This is
exactly the opposite of what needs to be done with
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa associated paradoxical reactions. When treating
with 5-HTP
aka 5HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa
aka dopa, decreasing the dose and then bringing
it up slowly will greatly prolong the time that patients
experience a prolonged exacerbation of symptoms, which is
the wrong approach. |
|
In
general, paradoxical reactions occur in the first week
or two of serotonin and dopamine neurotransmitter treatment. However, in Parkinson patients, it
is not uncommon to see paradoxical serotonin and
dopamine neurotransmitter reactions occur after
the patient has been treated for several weeks and
dopamine is ready to inflect into the phase 3 serotonin
and dopamine neurotransmitter therapeutic range.
While this primarily happens with Parkinson patients, it
can happen later in treatment in other serotonin and
dopamine neurotransmitter patients as well.
|
|
Paradoxical reactions indicate a need to increase the
5-HTP aka 5HTP
or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa dosing. When obtaining urinary
serotonin and dopamine neurotransmitter testing on a patient, if you spot a
paradoxical reaction, simply increase the
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa
dosing. Do not wait for the results of another urinary
serotonin and dopamine neurotransmitter test to
be returned. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5-HTP aka 5HTP or 5 HTP 9 |
|
|
|
|
|
A “Paradoxical
reaction” is where symptoms of
serotonin and dopamine neurotransmitter disease
such as depression, ADHD, etc.
exacerbate or
get worse in the early phases of
serotonin and dopamine neurotransmitter treatment as the
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa
is started
or being adjusted. For example, a weight
loss patient complains of increased
hunger, a patient with migraine
headaches complains of increased
headaches, or a patient with depression
complains of increased depression.
Examples are numerous. All related to
increased symptoms of serotonin and
dopamine neurotransmitter
disease
such as depression, ADHD, etc. The knee jerk response of
physicians is to lower the dose of
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa. This is exactly the opposite of
what needs to be done. If you have a
patient who experiences increased
symptoms of serotonin and dopamine neurotransmitter disease
such as depression, ADHD, etc.
early on in treatment the proper
treatment is to increase the
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa
dosing to the next step of the serotonin
and dopamine neurotransmitter treatment
protocol NOT decrease the dose. In
decreasing the dose and working up
slowly you will subject the patient to a
situation where they will experience the
exacerbation of symptoms for a prolonged
period of time and in all probability
the patient will quit treatment. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5-HTP aka 5HTP or 5 HTP 10 |
 |
|
|
|
|
|
HEARTBURN |
|
|
|
If a patient
complains of heart burn 10 to 15 minutes
after taking the serotonin and dopamine
neurotransmitter precursor pills the problem is
easily managed. The
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa pills are
larger capsules and in some patients if
they simply throw the pills in their
mouth and gulp them down the pills can
get stuck in the esophagus producing
irritation leading to symptoms of heart
burn. Management of this problem is to
tell the patients to hold the pills in
their mouth for 10 to 15 second with a
small amount of water until the surface
of the pills start to liquefy at which
point the pill will slide down the
esophagus into the stomach and not get
stuck on the way down. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5-HTP aka
5HTP or 5 HTP
11 |
 |
|
|
|
DIZZINESS |
|
|
|
If a patient complains of dizziness, the first thing
to do is take a history and ask the
patient, “What happened before we
started treating you if you missed a
meal? Did you get dizzy?” Odds are the
patient will say, “Yes.” We firmly
believe the problem is carbohydrate
addiction. Treatment is to increase the
patient to the next step of the
serotonin and dopamine dosing
protocol just as you would a paradoxical
reaction. The mechanism of action here
is complex. Discussion could easily fill
more than one four page newsletter. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5-HTP aka
5HTP or 5 HTP
13 |
 |
|
|
|
|
|
HYPERSOMNOLENCE |
|
|
|
|
|
If the patient
complains of extreme tiredness on
starting the serotonin and dopamine
neurotransmitter precursors
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa, take a sleep
history. Odds are that the patient had
poor sleep prior to treatment and will
have to pay back the acquired “sleep
debt” prior to sleeping normal. In
extreme cases have the patient start
5-HTP aka
5HTP or 5 HTP, tyrosine aka L-tyrosine,
and L-dopa aka dopa on Friday if they have the
weekend off and tell the patient, “Plan
on sleeping all weekend to catch up on
sleep." |
|
|
|
|
|
|
|
|
|
| |
| |
| |
|
If you need a medical speaker
for AMA Category I CME call NeuroResearch Clinics, Inc.
|
|
NeuroResearch Clinics, Inc.
only deals with and provides information to licensed health care
professionals. |
| |
| NeuroResearch Clinics, Inc |
| 1150 88th Ave W |
| Duluth, MN 55808 |
| Ph. 877-626-2220 |
| E-Mail: Info@NeuroAssist.com |
| |
|
DISCLAIMER: NeuroResearch is a research company that provides
speakers to programs for AMA category I continuing medical education
(CME) for physicians, continuing education for psychologists
approved by the American Psychological Association, and licenses
intellectual property for use. The NeuroResearch formulas and theory
of medicine is designed for the use of combining
5-HTP aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine, and L-dopa aka dopa
precursors of the serotonin and catecholamine systems. The formulas
are intended to be used as nutritional supplements and not as a drug
to treat, mitigate, treat, cure, or prevent disease. This web site
is intended to be educational purposes only. Constantly we receive
e-mails from people who are not licensed health care providers. We
wish we could answer them, but the new telemedicine laws that were
recently legislated (and put in place) prohibit us from providing
advice directly to people with no medical license or providing
medical care over the Internet. |
|
| |
| |
